Abbott

Similac(R) Survey Finds New Moms Want Convenient, Time-Saving Baby Products

Published in Healthcare Mergers, Acquisitions and Ventures Week, December 29th, 2007

According to a recent national survey(1) of new moms commissioned by Abbott's Similac brand, packing the diaper bag before leaving home with a baby takes close to 30 minutes. Nearly all moms surveyed (98 percent) agree that convenience is their top consideration when choosing products for themselves and their babies. One- third of moms surveyed said the one thing they never leave the house without is baby formula.

To help busy parents save time on the go, Abbott is introducing its two most popular baby formulas -- Similac(R) Advance(R) and Similac(R) Isomil(R) Advance(R) -- in new 8-fluid-ounce Ready To Feed bottles that require no mixing, measuring or preparation....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2007-12-29)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

2005 Limra International "Trends in Life Insurance Ownership Among U.S. Households" report
Global Study Shows Americans Caught in Cycle of Anxiety
Abbott
Abbott and HealthReach Increase Access to Health Care for Lake County's Uninsured With Newly Expanded Free Clinic
Abviva, Inc.
Abviva Announces Letter of Intent to Acquire Prion Developmental Laboratories
AcuNetx, Inc.
AcuNetx Subsidiary Reaches Agreement That Promises to Improve Prospects
Acute Leukemia
Sunesis Pharmaceuticals' SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
Acute Myelogenous Leukemia
Vion Pharmaceuticals Presents Preliminary Data from its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at ASH Annual Meeting
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry